- Home
- CMTL vs CNTX Comparison
CMTL vs CNTX Comparison
Compare CMTL & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- CNTX
- Stock Information
- Founded
- CMTL 1967
- CNTX 2015
- Country
- CMTL United States
- CNTX United States
- Employees
- CMTL N/A
- CNTX N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- CNTX Health Care
- Exchange
- CMTL Nasdaq
- CNTX Nasdaq
- Market Cap
- CMTL 51.3M
- CNTX 60.7M
- IPO Year
- CMTL N/A
- CNTX 2021
- Fundamental
- Price
- CMTL $1.35
- CNTX $0.94
- Analyst Decision
- CMTL Strong Buy
- CNTX Strong Buy
- Analyst Count
- CMTL 1
- CNTX 6
- Target Price
- CMTL $9.25
- CNTX $6.50
- AVG Volume (30 Days)
- CMTL 200.9K
- CNTX 264.6K
- Earning Date
- CMTL 06-17-2025
- CNTX 05-07-2025
- Dividend Yield
- CMTL N/A
- CNTX N/A
- EPS Growth
- CMTL N/A
- CNTX N/A
- EPS
- CMTL N/A
- CNTX N/A
- Revenue
- CMTL $496,641,000.00
- CNTX N/A
- Revenue This Year
- CMTL N/A
- CNTX N/A
- Revenue Next Year
- CMTL $4.14
- CNTX N/A
- P/E Ratio
- CMTL N/A
- CNTX N/A
- Revenue Growth
- CMTL N/A
- CNTX N/A
- 52 Week Low
- CMTL $1.21
- CNTX $0.55
- 52 Week High
- CMTL $5.16
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- CMTL 41.05
- CNTX 63.25
- Support Level
- CMTL $1.19
- CNTX $0.79
- Resistance Level
- CMTL $1.43
- CNTX $0.89
- Average True Range (ATR)
- CMTL 0.13
- CNTX 0.10
- MACD
- CMTL 0.01
- CNTX 0.03
- Stochastic Oscillator
- CMTL 42.11
- CNTX 79.73
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.